Revna Biosciences Named to Bloomberg’s Africa Startups to Watch 2025 

Revna Biosciences is honored to announce that we’ve been recognized on Bloomberg’s inaugural “Africa Startups to Watch 2025” list—a testament to our commitment to innovation across Africa. 

Bloomberg’s debut list shines a spotlight on African startups that are crafting inventive solutions for the continent’s most pressing challenges. The selection process was highly competitive, with over 2,000 startups from across the continent submitting entries. From these, 150 companies were shortlisted based on criteria such as innovation, scalability, market potential, and impact. Ultimately, only 25 startups were chosen for the final list positioning Revna Biosciences among the top 1% of Africa’s emerging ventures. 

This recognition not only validates the dedicated work we’ve put in over the past two and a half years but also strengthens our resolve to drive impactful change. A heartfelt thank you to Bloomberg, our exceptional team, investors, partners, and broader community. This achievement belongs to all of us, and it inspires us to keep pushing boundaries. 

Looking ahead, Revna Biosciences plans to expand its services across the continent, collaborate with academic institutions, and contribute to global research and biobanking initiatives. The company remains steadfast in its mission to revolutionize healthcare in Africa through innovation, collaboration, and a patient-centered approach. 

Here’s to the journey ahead and making an even greater impact together! 

[wpforms id=”24853″ title=”false”]